Table 1.
Compound | CDK9 | Akt | p42 | p38 | GSK3β | CK2 | TNKS2 |
---|---|---|---|---|---|---|---|
34% | 1% | 14% | 3% | 57% | 12% | 400 nM | |
31% | 2% | 3% | 3% | 11% | 1% | 15 nM | |
16% | 48% | 18% | 20% | 4% | 2% | 10 nM | |
6.2 µM | 14.7 µM | — | — | — | — | 660 nM | |
16.1 µM* | 13.3 µM | — | — | — | — | 16 nM | |
3.4 µM | 1.6 µM | 51% | 45% | 41% | 2% | 1,050 nM | |
28.3 µM* | 13.8 µM | — | — | — | — | 145 nM | |
12% | 7% | 2% | 3% | 7% | 1% | 5 nM | |
9% | 1% | 3% | 3% | 3% | 1% | 25 nM |
TNKS2 IC50 values are shown for comparison.
*The compound does not completely inhibit the enzyme at concentrations used. IC50 value extrapolated by the analysis software might be not accurately estimated.